Erik Peterson

Erik Peterson

Auto-generated profile, based on publicly available information

Erik Peterson

Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in JID Innovations
Verified
Journal Article
Open access
MSMaryanne M Senna
Maryanne M Senna
EPErik Peterson
Erik Peterson
IJIvan Jozic
Ivan Jozic
JCJeremy Cheret
Jeremy Cheret
RPRalf Paus
Ralf Paus
Lichen planopilaris (LPP) and frontal fibrosing alopecia (FFA) are primary, lymphocytic cicatricial hair loss disorders. These model epithelial stem cell (SC) diseases are thought to result from a CD8+ T-cell‒dominated immune attack on the hair follicle (HF) SC niche (bulge) after the latter has lost its immune privilege (IP) for as yet unknown reasons. This induces both apoptosis and pathological epithelial‒mesenchymal transition in epithelial SCs, thus depletes the bulge, causes fibrosis, and ultimately abrogates the HFs’ capacity to regenerate. In this paper, we synthesize recent progress in LPP and FFA pathobiology research, integrate our limited current understanding of the roles that genetic, hormonal, environmental, and other factors may play, and define major open questions. We propose that LPP and FFA share a common initial pathobiology, which then bifurcates into two distinct clinical phenotypes, with macrophages possibly playing a key role in phenotype determination. As particularly promising translational research avenues toward direly needed progress in the management of these disfiguring, deeply distressful cicatricial alopecia variants, we advocate to focus on the development of bulge IP and epithelial SC protectants such as, for example, topically effective, HF‒penetrating and immunoinhibitory preparations that contain tacrolimus, peroxisome proliferator–activated receptor-γ, and/or CB1 agonists.

29 June 2021 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
PAPrince Adotama
Prince Adotama
VCV. Callender
V. Callender
AKA. Kolla
A. Kolla
CYC. Young
C. Young
PJP. Jones
P. Jones
JSJ. Shapiro
J. Shapiro

30 September 2019 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
EPErik Peterson
Erik Peterson
DGDaniel Gutierrez
Daniel Gutierrez
NBNooshin K. Brinster
Nooshin K. Brinster
KSKristen I. Lo Sicco
Kristen I. Lo Sicco
JSJerry Shapiro
Jerry Shapiro

18 September 2019 in British Journal of Dermatology
Verified
Journal Article
Closed access
EPE. Peterson
E. Peterson
ASA. Steuer
A. Steuer
LFL. Franco
L. Franco
MNM.A. Nolan
M.A. Nolan
KSK. Lo Sicco
K. Lo Sicco
AFA.G. Franks
A.G. Franks